Theravance Biopharma, Inc. - Ordinary Shares (TBPH)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $877.45M
- P/E ratio
- —
- EPS
- —
- Volume
- 938,814
- 52-week high
- —
- 52-week low
- —
- Open
- $16.94
- Day high
- $16.96
- Day low
- $16.80
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $15.39M | -$13.58M | -$0.27 |
| 2024 | $14.5M | -$11.66M | -$0.24 |
| 2023 | $10.42M | -$22.09M | -$0.35 |
| 2022 | $13.2M | -$25.95M | -$0.34 |
| 2021 | $14.26M | -$79.68M | -$1.24 |
About Theravance Biopharma, Inc. - Ordinary Shares
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an investigational, once-daily norepinephrine reuptake inhibitor, Which is in Phase 3 clinical trials for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA). It has a strategic collaboration agreement with Viatris Inc. for the development and commercialization of revefenacin, including YUPELRI inhalation solution. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.
- CEO
- Rick E. Winningham
- Employees
- 90
- Country
- US
- IPO date
- May 16, 2014
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Theravance Biopharma, Inc. - Ordinary Shares's stock price today?
- TBPH is trading at $16.81 as of Jul 20, 2026.
- What is Theravance Biopharma, Inc. - Ordinary Shares's market cap?
- Theravance Biopharma, Inc. - Ordinary Shares (TBPH) has a market capitalization of $877.45M.
- Does Theravance Biopharma, Inc. - Ordinary Shares pay a dividend?
- Theravance Biopharma, Inc. - Ordinary Shares did not pay a dividend in its most recent reported fiscal year.
- What sector is Theravance Biopharma, Inc. - Ordinary Shares in?
- Theravance Biopharma, Inc. - Ordinary Shares operates in the Healthcare sector.